BPC-157

healing

Body Protection Compound-157

Mechanism of Action

A pentadecapeptide derived from human gastric juice. Promotes angiogenesis, upregulates growth factor expression (VEGF, EGF), modulates nitric oxide synthesis, and protects the GI tract. Demonstrated tissue-healing properties across muscle, tendon, ligament, bone, and gut in animal models.

Common Doses

250mcg

2x dailysubcutaneous

500mcg

1x dailysubcutaneous

500mcg

2x dailyoral

Common Protocols

Standard Healing4-8 weeks

250mcg subcutaneous 2x daily near injury site

Wolverine Stack6-8 weeks

BPC-157 250mcg + TB-500 2mg 2x/week

Gut Healing4-6 weeks

500mcg oral 2x daily on empty stomach

Safety Notes

No human clinical trials completed. Animal studies show favorable safety profile. Promotes angiogenesis — theoretical concern for existing tumors. Not FDA-approved. Almost all evidence comes from a single Croatian research group.

Legal Status

United States

Category 1 (pending)

Australia

Schedule 4

United Kingdom

Unregulated (RUO)

Research

BPC 157 — Stable gastric pentadecapeptide

review2018

Tendon healing with BPC 157 in rat model

animal2020

Ready to track this peptide?

Start Experiment

This information is for educational purposes only. N1X does not recommend, endorse, or facilitate access to any substance. Always consult a qualified healthcare provider before starting any protocol.